Show simple item record

Platelet consumption during neonatal extracorporeal life support (ECLS)

dc.contributor.authorPlötz, Franzen_US
dc.contributor.authorWildevuur, Walteren_US
dc.contributor.authorWildevuur, Charles R. H.en_US
dc.contributor.authorDelius, Ralph E.en_US
dc.contributor.authorBartlett, Roberten_US
dc.date.accessioned2010-04-14T14:05:38Z
dc.date.available2010-04-14T14:05:38Z
dc.date.issued1992en_US
dc.identifier.citationPlötz, Franz; Wildevuur, Walter; Wildevuur, Charles; Delius, Ralph; Bartlett, Robert (1992). "Platelet consumption during neonatal extracorporeal life support (ECLS)." Perfusion 7(1): 27-33. <http://hdl.handle.net/2027.42/68887>en_US
dc.identifier.issn0267-6591en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/68887
dc.description.abstractThis paper reports the results of a retrospective study of blood use and blood loss in 40 neonates during extracorporeal life support (ECLS). Immediately after onset of bypass 39±2.5ml platelets, 59.4±6.5ml packed red blood cells (PRBC) and 15.0±5.4ml fresh frozen plasma (FFP) per patient were needed. The average daily amount given per patient was 49.0±3.0ml of platelets and 48.0±3.4ml and 9.6±3.9ml of PRBC and FFP respectively. The 10 patients who had bleeding complications received 50.0±6.3ml/day of platelets compared to 49.0±3.4ml in the other patients. The majority of blood loss during the entire period of ECLS was from samples, averaging 43.0 ± 1.5ml/day. Neck wound drainage, 6.7±2.5ml/day per patient, lasted for the entire period.en_US
dc.format.extent3108 bytes
dc.format.extent495776 bytes
dc.format.mimetypetext/plain
dc.format.mimetypeapplication/pdf
dc.publisherSage Publicationsen_US
dc.titlePlatelet consumption during neonatal extracorporeal life support (ECLS)en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialitiesen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Hospitals, Ann Arboren_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Hospitals, Ann Arboren_US
dc.contributor.affiliationotherDepartment of Pediatrics, Neonatology, University Hospital, Groningen, NLen_US
dc.contributor.affiliationotherDepartment of Cardio-Pulmonary Surgery, Research Division, University Hospital, Groningen, The Netherlandsen_US
dc.contributor.affiliationotherDepartment of Cardio-Pulmonary Surgery, Research Division, University Hospital, Groningen, The Netherlandsen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/68887/2/10.1177_026765919200700106.pdf
dc.identifier.doi10.1177/026765919200700106en_US
dc.identifier.sourcePerfusionen_US
dc.identifier.citedreferenceBartlett RH, Gazzaniga AB, Toomasian JM et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg 1986; 204: 236-45.en_US
dc.identifier.citedreferenceMoront MG, Katz NM, Keszler M. et al. Extracorporeal membrane oxygenation for neonatal respiratory failure: a report of 50 cases. J Thorac Cardiovasc Surg 1989; 97: 706-14.en_US
dc.identifier.citedreferenceToomasian JM, Snedecor SM, Cornell RG et al. National experience with extracorporeal membrane oxygenation for newborn respiratory failure: data from 715 cases. Trans ASAIO 1988; 34: 140-47.en_US
dc.identifier.citedreferenceSinard JM, Bartlett RH Extracorporeal membrane oxygenation (ECMO): prolonged bedside cardiopulmonary bypass. Perfusion 1990; 5: 239-49.en_US
dc.identifier.citedreferenceCilley RE, Zwischenberger JB, Andrews AF et al. Intracranial hemorrhage during extracorporeal membrane oxygenation in neonates. Pediatrics 1986; 78: 699-704.en_US
dc.identifier.citedreferenceSell LL, Cullen ML, Whittlesey GC et al. Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment. J Pediatr Surg 1986 ; 21: 1087-91.en_US
dc.identifier.citedreferencePeters J., Radermacher P., Kuntz ME et al. Extracorporeal CO2-removal with a heparin coated artificial lung. Intensive Care Med 1988; 14: 578-84.en_US
dc.identifier.citedreferenceBartlett RH Extracorporeal life support in neonatal respiratory failure. In: Gille JP ed. Neonatal and respiratory failure: mechanisms and treatments. Paris: Elsevier, 1989: 107-15.en_US
dc.identifier.citedreferenceBindsley L. Adult ECMO performed with surface-heparinized equipment. Trans ASAIO 1988; 34: 1009-13.en_US
dc.identifier.citedreferenceWalker RH Technical manual of the American Association of Blood Banks. Arlington: American Association of Blood Banks, 1990.en_US
dc.identifier.citedreferenceMc Coy-Paddington D., Judd WJ, Knafl P. et al. Blood use during extracorporeal membrane oxygenation. Transfusion 1990; 30: 307-309.en_US
dc.identifier.citedreferenceBartlett RH, Andrews AF, Toomasian JM et al. Extracorporeal membrane oxygenation for newborn's respiratory failure: forty-five cases. Surgery 1982; 92: 425-33.en_US
dc.identifier.citedreferencede Jong Jcf, Smit Sibinga Cth, Wildevuur Ch RH. Platelet behavior in extracorporeal circulation (ECC). Transfusion 1979; 96: 727-30.en_US
dc.identifier.citedreferenceVidem V., Mollnes TE, Garred P., Svennevig JL Biocompatibility of extracorporeal circulation: in vitro comparison between heparin-coated and uncoated oxygenator circuit. J Thorac Cardiovasc Surg 1991; 101: 654-60.en_US
dc.identifier.citedreferencevan Oeveren W., Wildevuur Ch RH. Blood compatibility of cardiopulmonary bypass circuits. Perfusion 1987; 2: 237-44.en_US
dc.identifier.citedreferencevan Oeveren W., Wildevuur Ch RH, Kazatchkine MD Biocompatibility of extracorporeal circuits in heart surgery. Trans Sci 1990; 11: 5-33.en_US
dc.identifier.citedreferencevan Oeveren W., Jansen Njg, Bidstrup BP et al. Effects of approtinin on hemostatic mechanisms in cardiopulmonary bypass. Ann Thorac Surg 1987; 44: 640-45.en_US
dc.identifier.citedreferencevan Oeveren W., Eijsman L., Roozendaal KJ et al. Platelet preservation by aprotinin during cardiopulmonary bypass. Lancet 1988 ; 19: 644.en_US
dc.identifier.citedreferenceWildevuur Ch RH, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Platelet preservation during cardiopulmonary bypass with aprotinin. Eur J Cardio-thorac Surg 1989; 3: 533-38.en_US
dc.identifier.citedreferenceHorrow JC, Hlavacek J., Strong MD et al. Prophylatic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 70-74.en_US
dc.identifier.citedreferenceMook PH, Ennema JJ, Wildevuur Ch RH. Development of a small compact circuit for extracorporeal CO 2 removal. Life Support Syst 1986; 4 (suppl 1): 49-55.en_US
dc.identifier.citedreferenceWabeke E., Elstrodt JM, Mook PM, Gathier S, Wildevuur Ch RH. Clear prime for infant cardiopulmonary bypass: a miniaturized circuit. J Cardiovasc Surg 1988; 29: 117-22.en_US
dc.identifier.citedreferenceFunakubo A., Sakuma I., Fukui Y., Kawamura T. Development of a compact extracorporeal membrane oxygenation (ECMO) system. Artif Organs 1991 ; 15: 56-59.en_US
dc.identifier.citedreferenceDelius RE Physiology and pathophysiology of extracorporeal circulation. In: lonescu MY ed. Techniques in extracorporeal circulation. London: Butterworth (in press).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.